Reports for PENDOPHARM DIVISION OF PHARMASCIENCE INC
Company Name
PENDOPHARM DIVISION OF PHARMASCIENCE INC
Totals |
||
Shortage reports |
128 |
|
| Actual shortage: | 12 (9%) | |
| Anticipated shortage: | 0 (0%) | |
| Avoided shortage: | 5 (4%) | |
| Resolved: | 111 (87%) | |
Discontinuation Reports |
3 |
|
| To be discontinued: | 0 (0%) | |
| Discontinued: | 2 (67%) | |
| Reversed: | 1 (33%) | |
Late reports |
17 (13%) |
|
Overdue reports |
0 (0%) |
|
Shortage reports
| Brand name | Strength | Dosage | Status | Date Created | Date Updated | Reports |
|---|---|---|---|---|---|---|
| SOLYSTAT | 94.3MG | POWDER | Resolved | 2018-12-07 | 2018-12-20 | 68901 |
| SOLYSTAT | 94.3MG | POWDER | Avoided shortage | 2018-12-28 | 2019-04-12 | 70683 |
| SOLYSTAT | 1G | POWDER FOR SUSPENSION POWDER | Resolved | 2023-12-15 | 2024-03-22 | 213439 |
| SOLYSTAT | 1G | POWDER FOR SUSPENSION POWDER | Resolved | 2024-07-30 | 2024-10-16 | 234061 |
| SOLYSTAT | 250MG | SUSPENSION | Resolved | 2017-04-04 | 2017-10-12 | 5416 |
| SOLYSTAT | 250MG | SUSPENSION | Resolved | 2017-04-04 | 2017-10-12 | 5422 |
| SOLYSTAT | 250MG | SUSPENSION | Resolved | 2017-04-12 | 2017-10-05 | 6661 |
| SOLYSTAT | 250MG | SUSPENSION | Resolved | 2017-10-23 | 2018-02-05 | 26779 |
| SOLYSTAT | 250MG | SUSPENSION | Resolved | 2017-11-20 | 2018-03-13 | 29863 |
| SOLYSTAT | 250MG | SUSPENSION | Resolved | 2018-02-19 | 2018-03-13 | 40154 |
| SOLYSTAT | 250MG | SUSPENSION | Resolved | 2024-07-15 | 2024-08-31 | 232936 |
| SOLYSTAT | 250MG | SUSPENSION | Resolved | 2024-10-30 | 2025-01-18 | 241582 |
| SOLYSTAT | 250MG | SUSPENSION | Resolved | 2024-10-30 | 2024-11-09 | 241585 |
| SOLYSTAT | 250MG | SUSPENSION | Resolved | 2024-12-03 | 2025-02-24 | 244642 |
| SOLYSTAT | 250MG | SUSPENSION | Resolved | 2025-02-26 | 2025-04-03 | 251258 |
| SOLYSTAT | 250MG | SUSPENSION | Resolved | 2025-03-10 | 2025-05-09 | 252253 |
| SOLYSTAT | 250MG | SUSPENSION | Actual shortage | 2025-05-06 | 2025-05-07 | 256751 |
| SPASMHALT-8 | 325MG 400MG 8MG | TABLET | Actual shortage | 2017-03-21 | 2018-12-21 | 3761 |
| SPASMHALT-8 | 325MG 400MG 8MG | TABLET | Actual shortage | 2018-02-01 | 2018-02-02 | 38087 |
| XYLAC | 5MG | TABLET | Actual shortage | 2017-04-04 | 2018-12-22 | 5445 |
Discontinuation reports
| Brand name | Strength | Dosage | Status | Date Created | Date Updated | Reports |
|---|---|---|---|---|---|---|
| IBAVYR | 400MG | TABLET | Discontinued | 2023-01-20 | 2023-01-20 | 182029 |
| IBAVYR | 200MG | TABLET | Discontinued | 2023-01-20 | 2023-01-20 | 182060 |
| OCPHYL | 500MCG | SOLUTION | Reversed | 2017-04-10 | 2017-04-10 | 6237 |
Showing 1 to 3 of 3